Evolent Health, Inc.
EVH· NYSE
Released Aug 6, 2019, after the close
10-Q filed Aug 9, 2019, 40 days after period end · 0001628908-19-000059
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $191.96M | $144.30M | $107.07M | — |
| Net Income | -$31.62M | -$9.92M | -$16.91M | -$8.39M |
| EPS Diluted |
Evolent Health, Inc. · CIK 1628908 · Engraved from SEC EDGAR
| -$0.38 |
| -$0.13 |
| -$0.28 |
| -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.